PlainRecalls
FDA Food Low Class III Terminated

ACTIRON Dietary Supplement, ActiPharma, 100 tablets (24 bottles per case) ) (Lot 13309, Exp.: 01/26), UPC: 363102217104.

Reported: November 29, 2023 Initiated: September 28, 2023 #F-0463-2024

Product Description

ACTIRON Dietary Supplement, ActiPharma, 100 tablets (24 bottles per case) ) (Lot 13309, Exp.: 01/26), UPC: 363102217104.

Reason for Recall

FDA sample analysis of ACTIRON Dietary Supplement, 100 Tablets, Lot 13309, found the product did not meet folic acid specification compared to the label claim.

Details

Recalling Firm
ActiPharma, Inc.
Units Affected
607 bottles of 100 tablets each
Distribution
Domestic distribution, in Puerto Rico.
Location
Guaynabo, PR

Frequently Asked Questions

What product was recalled?
ACTIRON Dietary Supplement, ActiPharma, 100 tablets (24 bottles per case) ) (Lot 13309, Exp.: 01/26), UPC: 363102217104.. Recalled by ActiPharma, Inc.. Units affected: 607 bottles of 100 tablets each.
Why was this product recalled?
FDA sample analysis of ACTIRON Dietary Supplement, 100 Tablets, Lot 13309, found the product did not meet folic acid specification compared to the label claim.
Which agency issued this recall?
This recall was issued by the FDA Food on November 29, 2023. Severity: Low. Recall number: F-0463-2024.